These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 25471938)

  • 1. Nano-characterization of two closely related melanoma cell lines with different metastatic potential.
    Gostek J; Prauzner-Bechcicki S; Nimmervoll B; Mayr K; Pabijan J; Hinterdorfer P; Chtcheglova LA; Lekka M
    Eur Biophys J; 2015 Feb; 44(1-2):49-55. PubMed ID: 25471938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flexible, actin-based ridges colocalise with the beta1 integrin on the surface of melanoma cells.
    Poole K; Müller D
    Br J Cancer; 2005 Apr; 92(8):1499-505. PubMed ID: 15846299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biophysical and Biochemical Characteristics as Complementary Indicators of Melanoma Progression.
    Bobrowska J; Awsiuk K; Pabijan J; Bobrowski P; Lekki J; Sowa KM; Rysz J; Budkowski A; Lekka M
    Anal Chem; 2019 Aug; 91(15):9885-9892. PubMed ID: 31310097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Upregulation of alpha and beta integrin subunits in metastatic macrophage-melanoma fusion hybrids.
    Chakraborty AK; Funasaka Y; Ichihashi M; Pawelek JM
    Melanoma Res; 2009 Dec; 19(6):343-9. PubMed ID: 22760065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell migration and actin organization in cultured human primary, recurrent cutaneous and metastatic melanoma. Time-lapse and image analysis.
    Byers HR; Etoh T; Doherty JR; Sober AJ; Mihm MC
    Am J Pathol; 1991 Aug; 139(2):423-35. PubMed ID: 1867326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteomic analysis of membrane rafts of melanoma cells identifies protein patterns characteristic of the tumor progression stage.
    Baruthio F; Quadroni M; Rüegg C; Mariotti A
    Proteomics; 2008 Nov; 8(22):4733-47. PubMed ID: 18942674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparing surface properties of melanoma cells using time of flight secondary ions mass spectrometry.
    Bobrowska J; Moffat J; Awsiuk K; Pabijan J; Rysz J; Budkowski A; Reading M; Lekka M
    Analyst; 2016 Oct; 141(22):6217-6225. PubMed ID: 27704077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of integrins α3β1 and α5β1 and GlcNAc β1,6 glycan branching influences metastatic melanoma cell migration on fibronectin.
    Pocheć E; Janik M; Hoja-Łukowicz D; Link-Lenczowski P; Przybyło M; Lityńska A
    Eur J Cell Biol; 2013 Dec; 92(12):355-62. PubMed ID: 24290991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytoskeletal tubulin competes with actin to increase deformability of metastatic melanoma cells.
    Higgins G; Peres J; Abdalrahman T; Zaman MH; Lang DM; Prince S; Franz T
    Exp Cell Res; 2020 Sep; 394(2):112154. PubMed ID: 32598874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Common glycoproteins expressing polylactosamine-type glycans on matched patient primary and metastatic melanoma cells show different glycan profiles.
    Kinoshita M; Mitsui Y; Kakoi N; Yamada K; Hayakawa T; Kakehi K
    J Proteome Res; 2014 Feb; 13(2):1021-33. PubMed ID: 24354860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of beta1-integrins and N-cadherin in bladder cancer and melanoma cell lines.
    Laidler P; Gil D; Pituch-Noworolska A; Ciołczyk D; Ksiazek D; Przybyło M; Lityńska A
    Acta Biochim Pol; 2000; 47(4):1159-70. PubMed ID: 11996105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. β1,6-branched complex-type N-glycans affect FAK signaling in metastatic melanoma cells.
    Pocheć E; Ząbczyńska M; Bubka M; Homa J; Lityńska A
    Cancer Invest; 2016; 34(1):45-56. PubMed ID: 26745022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proton NMR characterization of intact primary and metastatic melanoma cells in 2D & 3D cultures.
    Ramachandran GK; Yeow CH
    Biol Res; 2017 Mar; 50(1):12. PubMed ID: 28302167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterisation of alpha3beta1 and alpha(v)beta3 integrin N-oligosaccharides in metastatic melanoma WM9 and WM239 cell lines.
    Kremser ME; Przybyło M; Hoja-Łukowicz D; Pocheć E; Amoresano A; Carpentieri A; Bubka M; Lityńska A
    Biochim Biophys Acta; 2008 Dec; 1780(12):1421-31. PubMed ID: 18755246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does glycosylation of melanoma cells influence their interactions with fibronectin?
    Litynska A; Przybylo M; Pochec E; Kremser E; Hoja-Lukowicz D; Sulowska U
    Biochimie; 2006 May; 88(5):527-34. PubMed ID: 16380202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new Mr 55,000 surface protein implicated in melanoma progression: association with a metastatic phenotype.
    Boukerche H; Baril P; Tabone E; Bérard F; Sanhadji K; Balme B; Wolf F; Perrot H; Thomas L
    Cancer Res; 2000 Oct; 60(20):5848-56. PubMed ID: 11059782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Osteonectin/SPARC induction by ectopic beta(3) integrin in human radial growth phase primary melanoma cells.
    Sturm RA; Satyamoorthy K; Meier F; Gardiner BB; Smit DJ; Vaidya B; Herlyn M
    Cancer Res; 2002 Jan; 62(1):226-32. PubMed ID: 11782382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell elasticity is an important indicator of the metastatic phenotype of melanoma cells.
    Sarna M; Zadlo A; Hermanowicz P; Madeja Z; Burda K; Sarna T
    Exp Dermatol; 2014 Nov; 23(11):813-8. PubMed ID: 25180917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PDMS substrate stiffness affects the morphology and growth profiles of cancerous prostate and melanoma cells.
    Prauzner-Bechcicki S; Raczkowska J; Madej E; Pabijan J; Lukes J; Sepitka J; Rysz J; Awsiuk K; Bernasik A; Budkowski A; Lekka M
    J Mech Behav Biomed Mater; 2015 Jan; 41():13-22. PubMed ID: 25460399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antigenic profile of tumor progression stages in human melanocytic nevi and melanomas.
    Elder DE; Rodeck U; Thurin J; Cardillo F; Clark WH; Stewart R; Herlyn M
    Cancer Res; 1989 Sep; 49(18):5091-6. PubMed ID: 2548711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.